[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 1987

Low Serum Cobalamin Levels in Primary Degenerative Dementia: Do Some Patients Harbor Atypical Cobalamin Deficiency States?

Author Affiliations

From the Departments of Neurology (Dr Karnaze) and Medicine (Dr Carmel), University of Southern California School of Medicine, and the Los Angeles County-University of Southern California Medical Center (Drs Karnaze and Carmel), Los Angeles.

Arch Intern Med. 1987;147(3):429-431. doi:10.1001/archinte.1987.00370030033007

• Serum cobalamin (vitamin B12) levels were analyzed retrospectively in 17 patients with primary degenerative dementia and 11 with specific demonstrable causes of dementia (secondary dementia). The prevalence of low cobalamin levels was significantly increased in primary dementia (29% vs 0% in secondary dementia). Because typical findings of deficiency often seemed absent, we prospectively studied two other patients with primary dementia and low cobalamin levels. Neither of these two had megaloblastic anemia; one had a normal Schilling test while the other's was borderline. Despite this absence of the expected findings, the deoxyuridine suppression test gave biochemical evidence of cobalamin deficiency in both cases. Our survey of 28 patients thus established that low serum cobalamin levels are frequent in primary dementia. Our findings in the two prospectively studied cases (as well as in some of the patients in the survey) indicate that these levels are associated in at least some cases with an atypical deficiency state rather than with disorders such as pernicious anemia. Such atypical deficiency states cannot be identified by classic hematological criteria or by the Schilling test.

(Arch Intern Med 1987;147:429-431)